Gülce Sarı

997 total citations · 1 hit paper
18 papers, 692 citations indexed

About

Gülce Sarı is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Gülce Sarı has authored 18 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Epidemiology and 5 papers in Immunology. Recurrent topics in Gülce Sarı's work include Ubiquitin and proteasome pathways (4 papers), Immune Cell Function and Interaction (3 papers) and Hepatitis Viruses Studies and Epidemiology (3 papers). Gülce Sarı is often cited by papers focused on Ubiquitin and proteasome pathways (4 papers), Immune Cell Function and Interaction (3 papers) and Hepatitis Viruses Studies and Epidemiology (3 papers). Gülce Sarı collaborates with scholars based in Türkiye, Netherlands and Belgium. Gülce Sarı's co-authors include Esra Çapanoğlu, Tuğba Özdal, Senem Kamiloğlu, Kenneth L. Rock, Betül Karademir, Dilek Özbeyli, Özlem Tuğçe Çilingir‐Kaya, Meral Yüksel, Dilek Boyacıoğlu and André Boonstra and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Gülce Sarı

17 papers receiving 673 citations

Hit Papers

Guidelines for cell viability assays 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gülce Sarı Türkiye 9 194 109 71 69 63 18 692
Mahshid Ghasemi Australia 5 228 1.2× 115 1.1× 99 1.4× 96 1.4× 71 1.1× 8 751
Rajiv Lall United States 9 216 1.1× 121 1.1× 138 1.9× 56 0.8× 87 1.4× 23 1.1k
Jiahao Lin China 16 239 1.2× 82 0.8× 115 1.6× 38 0.6× 64 1.0× 45 704
Anil Kumar Banothu India 16 348 1.8× 144 1.3× 81 1.1× 114 1.7× 60 1.0× 46 935
Xin Deng China 15 335 1.7× 119 1.1× 127 1.8× 81 1.2× 48 0.8× 58 987
Tong Li China 19 376 1.9× 90 0.8× 130 1.8× 56 0.8× 65 1.0× 83 1.1k
Shuangying Gui China 17 176 0.9× 128 1.2× 98 1.4× 48 0.7× 46 0.7× 44 593
Yan Jia China 20 383 2.0× 123 1.1× 121 1.7× 62 0.9× 95 1.5× 64 1.3k
Jayabalan Nirmal India 19 179 0.9× 86 0.8× 115 1.6× 33 0.5× 35 0.6× 73 1.1k
Maliheh Paknejad Iran 18 339 1.7× 144 1.3× 104 1.5× 65 0.9× 42 0.7× 59 830

Countries citing papers authored by Gülce Sarı

Since Specialization
Citations

This map shows the geographic impact of Gülce Sarı's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gülce Sarı with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gülce Sarı more than expected).

Fields of papers citing papers by Gülce Sarı

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gülce Sarı. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gülce Sarı. The network helps show where Gülce Sarı may publish in the future.

Co-authorship network of co-authors of Gülce Sarı

This figure shows the co-authorship network connecting the top 25 collaborators of Gülce Sarı. A scholar is included among the top collaborators of Gülce Sarı based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gülce Sarı. Gülce Sarı is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jannuzzi, Ayşe Tarbın, Gülce Sarı, Yusuf Yılmaz, et al.. (2025). HBV Infection Drives PSMB5-Dependent Proteasomal Activation in Humanized Mice and HBV-Associated HCC. Viruses. 17(11). 1454–1454.
2.
Boonstra, André & Gülce Sarı. (2025). HBV cccDNA: The Molecular Reservoir of Hepatitis B Persistence and Challenges to Achieve Viral Eradication. Biomolecules. 15(1). 62–62. 2 indexed citations
3.
Sarı, Gülce, et al.. (2024). IRF2 loss is associated with reduced MHC I pathway transcripts in subsets of most human cancers and causes resistance to checkpoint immunotherapy in human and mouse melanomas. Journal of Experimental & Clinical Cancer Research. 43(1). 276–276. 4 indexed citations
4.
Sarı, Gülce & Kenneth L. Rock. (2023). Tumor immune evasion through loss of MHC class-I antigen presentation. Current Opinion in Immunology. 83. 102329–102329. 34 indexed citations
5.
Sarı, Gülce, Gertine W. van Oord, Zongdi Feng, et al.. (2021). Treatment induced clearance of hepatitis E viruses by interferon‐lambda in liver‐humanized mice. Liver International. 41(12). 2866–2873. 12 indexed citations
6.
Sarı, Gülce, Gertine W. van Oord, Martijn D. B. van de Garde, et al.. (2021). Sexual Dimorphism in Hepatocyte Xenograft Models. Cell Transplantation. 30. 4211063988–4211063988. 4 indexed citations
7.
Jannuzzi, Ayşe Tarbın, Ayşe Mine Yılmaz, Gülce Sarı, et al.. (2020). Higher proteotoxic stress rather than mitochondrial damage is involved in higher neurotoxicity of bortezomib compared to carfilzomib. Redox Biology. 32. 101502–101502. 16 indexed citations
8.
Sarı, Gülce, Kristiaan Wouters, Jeanine E. Roeters van Lennep, et al.. (2020). A mouse model of humanized liver shows a human-like lipid profile, but does not form atherosclerotic plaque after western type diet. Biochemical and Biophysical Research Communications. 524(2). 510–515. 10 indexed citations
9.
Kamiloğlu, Senem, Gülce Sarı, Tuğba Özdal, & Esra Çapanoğlu. (2020). Guidelines for cell viability assays. SHILAP Revista de lepidopterología. 1(3). 332–349. 476 indexed citations breakdown →
10.
Sarı, Gülce, et al.. (2019). PS-154-Dissecting the different roles of ORF3 in HEV spread and fecal shedding in a humanized mouse model. Journal of Hepatology. 70(1). e97–e97. 1 indexed citations
11.
Sarı, Gülce, Martijn D. B. van de Garde, Jolanda J.C. Voermans, et al.. (2019). Hepatitis E Virus Shows More Genomic Alterations in Cell Culture than In Vivo. Pathogens. 8(4). 255–255. 9 indexed citations
12.
Sarı, Gülce, et al.. (2019). Proteasome Inhibitors in Cancer Therapy and their Relation to Redox Regulation. Current Pharmaceutical Design. 24(44). 5252–5267. 1 indexed citations
13.
Karademir, Betül, Gülce Sarı, Ayşe Tarbın Jannuzzi, et al.. (2018). Proteomic approach for understanding milder neurotoxicity of Carfilzomib against Bortezomib. Scientific Reports. 8(1). 16318–16318. 26 indexed citations
15.
Özbeyli, Dilek, et al.. (2017). Protective effects of different exercise modalities in an Alzheimer’s disease-like model. Behavioural Brain Research. 328. 159–177. 53 indexed citations
16.
Sarı, Gülce, et al.. (2014). Identification of a novel HLA‐A*26 allele, HLA‐A*26:01:36, in a Turkish family by sequence‐based typing. Tissue Antigens. 84(6). 580–581. 4 indexed citations
17.
Tozkır, Hilmi, et al.. (2014). Increased frequency of class I and II anti‐human leukocyte antigen antibodies in systemic lupus erythematosus and scleroderma and associated factors: a comparative study. International Journal of Rheumatic Diseases. 19(12). 1304–1309. 8 indexed citations
18.
Tozkır, Hilmi, et al.. (2012). The Presence of Donor-Specific Antibodies in Renal Transplantation. Transplantation Proceedings. 44(6). 1667–1669. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026